These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2154757)

  • 21. Relationship of hormones and growth factors to colon cancer.
    Conteas CN; Desai TK; Arlow FA
    Gastroenterol Clin North Am; 1988 Dec; 17(4):761-72. PubMed ID: 3068140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of chemotherapy to hormonal levels in postmenopausal breast cancer patients.
    Pribylova O; Springer D; Svobodnik A; Kyr M; Zima T; Petruzelka L
    Neoplasma; 2008; 55(4):294-8. PubMed ID: 18505339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
    Awada A
    Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormone receptors and cancer of the breast].
    Basso L; Bertolotti MG
    Arch Sci Med (Torino); 1982; 139(1):63-8. PubMed ID: 6285852
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant treatment of breast cancer.
    Akerley WL
    R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
    [No Abstract]   [Full Text] [Related]  

  • 26. Re: Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized Trial.
    Ferretti G; Felici A; Carlini P; Cognetti F
    J Natl Cancer Inst; 2007 Sep; 99(18):1416. PubMed ID: 17848675
    [No Abstract]   [Full Text] [Related]  

  • 27. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of mitomycin regimens in advanced breast cancer therapy.
    Legha SS
    Clin Ther; 1985; 7(3):286-307. PubMed ID: 3888391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.
    Thai le M; Labrinidis A; Hay S; Liapis V; Bouralexis S; Welldon K; Coventry BJ; Findlay DM; Evdokiou A
    Cancer Res; 2006 May; 66(10):5363-70. PubMed ID: 16707463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study.
    Bottomley A; Biganzoli L; Cufer T; Coleman RE; Coens C; Efficace F; Calvert HA; Gamucci T; Twelves C; Fargeot P; Piccart M;
    J Clin Oncol; 2004 Jul; 22(13):2576-86. PubMed ID: 15226325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pamidronate and 1,24(S)-dihydroxyvitamin D2 synergistically inhibit the growth of myeloma, breast and prostate cancer cells.
    Wigington DP; Strugnell SA; Knutson JC
    Anticancer Res; 2005; 25(3B):1909-17. PubMed ID: 16158925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer: metastatic.
    Johnston S; Stebbing J
    Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
    [No Abstract]   [Full Text] [Related]  

  • 33. [Questions on hormone and chemotherapy in metastatic breast cancer].
    Brunner KW
    Gynakol Rundsch; 1988; 28 Suppl 1():76-83. PubMed ID: 3042537
    [No Abstract]   [Full Text] [Related]  

  • 34. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
    Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relation dose efficacy in chemotherapy: the example of breast cancer].
    Chevallier B; Perrocheau G
    Bull Cancer; 1995; 82 Suppl 1():9s-15s. PubMed ID: 7626858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer.
    Seidman AD; Hudis CA; Fennelly D; Raptis G; Baselga J; Norton L
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):108-16. PubMed ID: 7481852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interferon and growth factors in the light of the new evolutionary theory of hormones].
    Inglot AD
    Postepy Hig Med Dosw; 1984; 38(5-6):633-53. PubMed ID: 6085590
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemotherapy of cancer of the breast in the metastatic phase].
    Clavel M; Biron P; Chauvin F; Guastalla JP; Rebattu P; el Foudeh M
    Bull Cancer; 1989; 76(1):75-85. PubMed ID: 2653473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1985; 5(12):5 p.. PubMed ID: 3908920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.